KR100797049B1 - 아토피성 피부염에 치료효과를 갖는 cd4 t 세포 - Google Patents
아토피성 피부염에 치료효과를 갖는 cd4 t 세포 Download PDFInfo
- Publication number
- KR100797049B1 KR100797049B1 KR1020060081511A KR20060081511A KR100797049B1 KR 100797049 B1 KR100797049 B1 KR 100797049B1 KR 1020060081511 A KR1020060081511 A KR 1020060081511A KR 20060081511 A KR20060081511 A KR 20060081511A KR 100797049 B1 KR100797049 B1 KR 100797049B1
- Authority
- KR
- South Korea
- Prior art keywords
- cells
- atopic dermatitis
- cell
- gamma
- alpha
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2304—Interleukin-4 (IL-4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/59—Lectins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
- 과립구-마크로파지 콜로니자극인자(GM-CSF), 인터페론-감마(IFN-gamma), 종양괴사인자-알파(TNF-alpha), 렉틴(Lectin), 인터루킨-2(IL-2) 및 인터루킨-4(IL-4)를 첨가한 배지에서 활성화된 CD4 T 세포를 유효성분으로 함유하는 아토피성 피부염 치료용 세포치료제.
- 제1항에 있어서, 상기 CD4 T 세포는 환자에서 분리된 자가(autologous) 세포인 것을 특징으로 하는 아토피성 피부염 치료용 세포치료제.
- CD4 T 세포를 과립구-마크로파지 콜로니자극인자(GM-CSF), 인터페론-감마(IFN-gamma), 종양괴사인자-알파(TNF-alpha), 렉틴(Lectin), 인터루킨-2(IL-2) 및 인터루킨-4(IL-4)를 첨가한 배지에서 활성화시키는 단계를 포함하는 아토피성 피부염 치료 활성을 갖는 CD4 T 세포의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060081511A KR100797049B1 (ko) | 2006-08-28 | 2006-08-28 | 아토피성 피부염에 치료효과를 갖는 cd4 t 세포 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060081511A KR100797049B1 (ko) | 2006-08-28 | 2006-08-28 | 아토피성 피부염에 치료효과를 갖는 cd4 t 세포 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100797049B1 true KR100797049B1 (ko) | 2008-01-23 |
Family
ID=39218913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060081511A KR100797049B1 (ko) | 2006-08-28 | 2006-08-28 | 아토피성 피부염에 치료효과를 갖는 cd4 t 세포 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100797049B1 (ko) |
-
2006
- 2006-08-28 KR KR1020060081511A patent/KR100797049B1/ko active IP Right Grant
Non-Patent Citations (1)
Title |
---|
Current Opinion in Immunology, vol.16, pp.768-774 (2004) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5792622B2 (ja) | ナチュラルキラー細胞の製造方法 | |
US20190276803A1 (en) | Method of culturing immune cells, kit for thereof, immune cell cultured medium obtained by same method, cosmetic composition and pharmaceutical composition comprising thereof | |
Kurosawa et al. | Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. | |
AU2019215034C1 (en) | Method of producing natural killer cells and composition for treating cancer | |
JP2019504632A (ja) | Nk細胞培養用培地添加キット、及びキットを用いるnk細胞培養方法 | |
KR101400900B1 (ko) | 탄시논을 유효성분으로 함유하는 자연살해세포 분화 또는 활성 증진용 조성물 | |
CN105886469B (zh) | Cik细胞及其培养方法和应用 | |
WO2019152663A1 (en) | Method of producing natural killer cells and composition for treating cancer | |
CA2588685A1 (en) | Alpha thymosin peptides as cancer vaccine adjuvants | |
KR100797050B1 (ko) | 아토피성 피부염에 치료효과를 갖는 cd8 t 세포 | |
KR100797049B1 (ko) | 아토피성 피부염에 치료효과를 갖는 cd4 t 세포 | |
JP2022023136A (ja) | T細胞の拡張及び活性化の方法 | |
KR20120095320A (ko) | 레티날 또는 레티노산을 유효성분으로 포함하는 자연살해세포의 독성 억제를 위한 세포보호용 조성물 | |
TW200908988A (en) | Therapeutic agent for cancer | |
CN106119192B (zh) | 组合物及其在cik细胞培养中的应用 | |
EP2050455A1 (en) | Compounds leading to an increase of the IL-12/IL-10 ratio and their use for therapy of infectious and proliferative diseases | |
JP2005124568A (ja) | 細胞活性化方法及びこれを用いる細胞製造方法並びに医薬組成物 | |
EP1871872B1 (en) | Method for activating cd8 t cells | |
US20060110372A1 (en) | Regulatory cells that control T cell immunoreactivity | |
RU2780848C2 (ru) | Способ получения природных клеток-киллеров и композиция для лечения рака | |
KR102237646B1 (ko) | 타크롤리무스 및 비타민d를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
KR20190093500A (ko) | Cd56+ 자연살해세포를 포함하는 항암용 조성물 | |
LotzovÁ et al. | Induction of cytotoxic lymphocyte subsets against leukemia by stimulation with AML blasts | |
AU4029500A (en) | Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs) | |
WO2003018784A1 (fr) | Procede de production de lymphocytes t humains specifiques d'un antigene et medicaments associes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130111 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140313 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150108 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20160118 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170109 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180108 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190114 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20200113 Year of fee payment: 13 |